Literature DB >> 24091330

p16(INK4a) protects against dysfunctional telomere-induced ATR-dependent DNA damage responses.

Yang Wang, Norman Sharpless, Sandy Chang.   

Abstract

Dysfunctional telomeres limit cellular proliferative capacity by activating the p53-p21- and p16(INK4a)-Rb-dependent DNA damage responses (DDRs). The p16(INK4a) tumor suppressor accumulates in aging tissues, is a biomarker for cellular senescence, and limits stem cell function in vivo. While the activation of a p53-dependent DDR by dysfunctional telomeres has been well documented in human cells and mouse models, the role for p16(INK4a) in response to telomere dysfunction remains unclear. Here, we generated protection of telomeres 1b p16-/- mice (Pot1bΔ/Δ;p16-/-) to address the function of p16(INK4a) in the setting of telomere dysfunction in vivo. We found that deletion of p16(INK4a) accelerated organ impairment and observed functional defects in highly proliferative organs, including the hematopoietic system, small intestine, and testes. Pot1bΔ/Δ;p16-/- hematopoietic cells exhibited increased telomere loss, increased chromosomal fusions, and telomere replication defects. p16(INK4a) deletion enhanced the activation of the ATR-dependent DDR in Pot1bΔ/Δ hematopoietic cells, leading to p53 stabilization, increased p21-dependent cell cycle arrest, and elevated p53-dependent apoptosis. In contrast to p16(INK4a), deletion of p21 did not activate ATR, rescued proliferative defects in Pot1bΔ/Δ hematopoietic cells, and significantly increased organismal lifespan. Our results provide experimental evidence that p16(INK4a) exerts protective functions in proliferative cells bearing dysfunctional telomeres.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24091330      PMCID: PMC3784543          DOI: 10.1172/JCI69574

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  63 in total

Review 1.  Telomere dysfunction and tumour suppression: the senescence connection.

Authors:  Yibin Deng; Suzanne S Chan; Sandy Chang
Journal:  Nat Rev Cancer       Date:  2008-06       Impact factor: 60.716

2.  Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders.

Authors:  Darren J Baker; Tobias Wijshake; Tamar Tchkonia; Nathan K LeBrasseur; Bennett G Childs; Bart van de Sluis; James L Kirkland; Jan M van Deursen
Journal:  Nature       Date:  2011-11-02       Impact factor: 49.962

3.  Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes.

Authors:  Yan Liu; Soren M Johnson; Yuri Fedoriw; Arlin B Rogers; Hong Yuan; Janakiraman Krishnamurthy; Norman E Sharpless
Journal:  Blood       Date:  2011-01-18       Impact factor: 22.113

4.  Nucleotide deficiency promotes genomic instability in early stages of cancer development.

Authors:  Assaf C Bester; Maayan Roniger; Yifat S Oren; Michael M Im; Dan Sarni; Malka Chaoat; Aaron Bensimon; Gideon Zamir; Donna S Shewach; Batsheva Kerem
Journal:  Cell       Date:  2011-04-29       Impact factor: 41.582

Review 5.  Telomere maintenance and human bone marrow failure.

Authors:  Rodrigo T Calado; Neal S Young
Journal:  Blood       Date:  2008-01-31       Impact factor: 22.113

Review 6.  How shelterin protects mammalian telomeres.

Authors:  Wilhelm Palm; Titia de Lange
Journal:  Annu Rev Genet       Date:  2008       Impact factor: 16.830

7.  Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicit phenotypes resembling dyskeratosis congenita.

Authors:  Hua He; Yang Wang; Xiaolan Guo; Sonal Ramchandani; Jin Ma; Mei-Feng Shen; Dennis A Garcia; Yibin Deng; Asha S Multani; Mingjian James You; Sandy Chang
Journal:  Mol Cell Biol       Date:  2008-10-20       Impact factor: 4.272

8.  Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1.

Authors:  Eros Lazzerini Denchi; Titia de Lange
Journal:  Nature       Date:  2007-08-08       Impact factor: 49.962

9.  Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis.

Authors:  Xiaolan Guo; Yibin Deng; Yahong Lin; Wilfredo Cosme-Blanco; Suzanne Chan; Hua He; Guohua Yuan; Eric J Brown; Sandy Chang
Journal:  EMBO J       Date:  2007-10-18       Impact factor: 14.012

10.  TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.

Authors:  Amanda J Walne; Tom Vulliamy; Richard Beswick; Michael Kirwan; Inderjeet Dokal
Journal:  Blood       Date:  2008-07-30       Impact factor: 22.113

View more
  15 in total

1.  Multiple Pathways Control the Reactivation of Telomerase in HTLV-I-Associated Leukemia.

Authors:  Marcia Bellon; Christophe Nicot
Journal:  Int J Cancer Oncol       Date:  2015-06-02

Review 2.  The Connection Between Cell Fate and Telomere.

Authors:  Ayse Basak Engin; Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Balance between senescence and apoptosis is regulated by telomere damage-induced association between p16 and caspase-3.

Authors:  Shanmugam Panneer Selvam; Braden M Roth; Rose Nganga; Jisun Kim; Marion A Cooley; Kristi Helke; Charles D Smith; Besim Ogretmen
Journal:  J Biol Chem       Date:  2018-05-10       Impact factor: 5.157

4.  Genetic Ablation of p16INK4a Does Not Protect against Cellular Senescence in Mouse Models of Chronic Obstructive Pulmonary Disease/Emphysema.

Authors:  Isaac K Sundar; Kahkashan Rashid; Janice Gerloff; Dongmei Li; Irfan Rahman
Journal:  Am J Respir Cell Mol Biol       Date:  2018-08       Impact factor: 7.748

Review 5.  Do telomeres adapt to physiological stress? Exploring the effect of exercise on telomere length and telomere-related proteins.

Authors:  Andrew T Ludlow; Lindsay W Ludlow; Stephen M Roth
Journal:  Biomed Res Int       Date:  2013-12-24       Impact factor: 3.411

6.  Telomere dysfunction suppresses multiple endocrine neoplasia in mice.

Authors:  Ji-Hyeon Lee; Miriam Anver; Maria Kost-Alimova; Alexei Protopopov; Ronald A DePinho; Sushil G Rane
Journal:  Genes Cancer       Date:  2014-09

7.  p16 controls epithelial cell growth and suppresses carcinogenesis through mechanisms that do not require RB1 function.

Authors:  M Sen; N Akeno; A Reece; A L Miller; D S Simpson; K A Wikenheiser-Brokamp
Journal:  Oncogenesis       Date:  2017-04-17       Impact factor: 7.485

8.  Pot1 OB-fold mutations unleash telomere instability to initiate tumorigenesis.

Authors:  P Gu; Y Wang; K K Bisht; L Wu; L Kukova; E M Smith; Y Xiao; S M Bailey; M Lei; J Nandakumar; S Chang
Journal:  Oncogene       Date:  2016-11-21       Impact factor: 9.867

Review 9.  The role of telomere binding molecules for normal and abnormal hematopoiesis.

Authors:  Kentaro Hosokawa; Fumio Arai
Journal:  Int J Hematol       Date:  2018-03-17       Impact factor: 2.319

10.  Dysfunctional telomeres induce p53-dependent and independent apoptosis to compromise cellular proliferation and inhibit tumor formation.

Authors:  Yang Wang; Xinwei Wang; Elsa R Flores; Jian Yu; Sandy Chang
Journal:  Aging Cell       Date:  2016-04-26       Impact factor: 11.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.